市場調査レポート

商品コード

1566201

血糖モニタリングデバイスの市場規模、シェア、成長分析、製品別、用途別、地域別 - 産業予測、2024年～2031年

Blood Glucose Monitoring Devices Market Size, Share, Growth Analysis, By Product (Blood Glucose Monitors, Glucose Monitoring Strips), By Application (Hospitals and Clinics, Diagnostic Centers), By Region - Industry Forecast 2024-2031

出版日: 2024年10月06日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

血糖モニタリングデバイスの世界市場規模は、2022年に125億米ドルと評価され、2023年の135億4,000万米ドルから2031年には237億7,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは8.30％で成長する見通しです。

血糖モニタリング（BGM）市場は、効果的な糖尿病管理に対する需要の高まりによって顕著な成長を遂げています。BGM機器は、糖尿病患者がグルコースメーターを使用して血糖値をモニターすることを可能にし、食事、インスリン投与量、運動量について十分な情報に基づいた意思決定を行うことを可能にします。自己血糖測定（SMBG）技術を利用することで、患者は毛細血管グルコース濃度の正確な測定値を即座に得ることができ、低血糖や高血糖などの状態の迅速な診断が容易になります。この技術的進歩は、患者のエンパワーメントとセルフケアを強化するだけでなく、より健康的なライフスタイルの選択を促します。様々な形状、サイズ、価格帯のグルコースメーターが販売されていることから、糖尿病管理ソリューションの重要性に対する認識が高まっています。このような消費者の意識の高まりは、特に糖尿病モニタリング機器にアクセスしにくい未開拓地域における大きな市場機会を促進すると期待されています。米国における自己血糖測定器市場は、より良い血糖コントロールと革新的な管理ソリューションに対する継続的な需要に牽引され、持続的な成長を遂げると予測されます。糖尿病の有病率が上昇を続ける中、BGM市場は、先進技術の統合と糖尿病治療における患者ニーズの深い理解に支えられ、拡大に向けて戦略的に位置づけられています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Abbott（US）
Medtronic plc（Ireland）
F. Hoffmann-La Roche Ltd（Switzerland）
Dexcom, Inc.（US）
Sanofi（France）
Novo Nordisk（Denmark）
Insulet Corporation（US）
Ypsomed Holdings（Switzerland）
Glysens Incorporated
ARKRAY, Inc.（Japan）
Bayer AG（Germany）
AgaMatrix, Inc.（US）
Trividia Health, Inc.（US）
MediWise Ltd.（UK）
DiaMonTech AG（Germany）
B. Braun Melsungen AG（Germany）
Sinocare, Inc.（China）
Nipro Corporation（Japan）
Menarini Diagnostics（Italy）
Beurer GmbH（Germany）
Prodigy Diabetes Care, LLC（US）
Omron Healthcare, Inc.（Japan）

Product Code: SQMIG35A2338

Global Blood Glucose Monitoring Devices Market size was valued at USD 12.50 billion in 2022 and is poised to grow from USD 13.54 billion in 2023 to USD 23.77 billion by 2031, growing at a CAGR of 8.30% during the forecast period (2024-2031).

The blood glucose monitoring (BGM) market is experiencing notable growth driven by the increasing demand for effective diabetes management. BGM devices enable individuals with diabetes to monitor their blood glucose levels using a glucose meter, allowing them to make informed decisions about their diet, insulin dosage, and physical activity. By utilizing self-monitoring blood glucose (SMBG) technology, patients can instantly obtain accurate readings of their capillary glucose concentration, facilitating rapid diagnosis of conditions such as hypoglycemia and hyperglycemia. This technological advancement not only enhances patient empowerment and self-care but also encourages healthier lifestyle choices. With a diverse range of glucose meters available in various shapes, sizes, and price points, there is a growing awareness of the importance of diabetes management solutions. This increasing consumer awareness is expected to fuel significant market opportunities, especially in underserved areas where diabetes monitoring devices are least accessible. The market for self-monitoring blood glucose devices in the U.S. is projected to achieve sustainable growth, driven by the ongoing demand for better glycemic control and innovative management solutions. As the prevalence of diabetes continues to rise, the BGM market strategically positions itself for expansion, supported by the integration of advanced technology and a deeper understanding of patient needs in diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Monitoring Devices Market Segmental Analysis

Global Blood Glucose Monitoring Devices Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Blood Glucose Monitors, Glucose Monitoring Strips, and Lancets. Based on Application, the market is segmented into Hospitals and Clinics, Diagnostic Centers, and Home Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Blood Glucose Monitoring Devices Market

The global Blood Glucose Monitoring Devices market is significantly driven by the alarming rise in diabetes prevalence, particularly among the aging population susceptible to the disease. With an estimated 537 million adults diagnosed globally, as reported by the International Diabetes Federation, countries like China, India, the United States, Brazil, and Mexico represent a staggering 51.6% of this demographic. Contributing factors such as rapid urbanization and increasingly sedentary lifestyles further exacerbate this public health concern. Additionally, heightened awareness about diabetes management and preventive care, along with continuous innovations in monitoring technology, is propelling market growth and driving the adoption of these essential devices.

Restraints in the Global Blood Glucose Monitoring Devices Market

The global blood glucose monitoring devices market faces significant restraints from the high costs associated with these devices and the inadequacy of reimbursements. In developing nations like China and India, the burden of purchasing blood glucose monitors and test strips falls solely on patients, leading to limited accessibility and affordability. In contrast, developed countries such as Canada and certain European nations impose restrictions on the number of annually provided test strips based on specific treatment plans, discouraging comprehensive monitoring for many patients. This situation ultimately curtails market growth, as patients often forego necessary monitoring due to financial constraints.

Market Trends of the Global Blood Glucose Monitoring Devices Market

The Global Blood Glucose Monitoring Devices market is experiencing significant growth driven by technological advancements and innovative solutions aimed at improving patient care. As medical device companies shift from traditional manufacturing to becoming problem solvers, the integration of cloud computing and the Internet of Things (IoT) is revolutionizing diabetes management. Cutting-edge devices, including non-invasive monitoring solutions utilizing radio frequency and multi-sensor technology, as well as optical methods for glucose measurement, enhance accuracy and user-friendliness. This trend towards more sophisticated and connected devices not only caters to the rising prevalence of diabetes but also supports real-time remote monitoring, thereby enhancing clinical outcomes and reducing healthcare costs.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Blood Glucose Monitoring Devices Market by Product

Market Overview
Blood Glucose Monitors
- Single Point Blood Glucose Meters
- Continuous Glucose Monitoring Systems
- Sensors
- Transmitter and Receivers
- External Monitor
Glucose Monitoring Strips
Lancets

Blood Glucose Monitoring Devices Market by Application

Market Overview
Hospitals and Clinics
Diagnostic Centers
Home Settings

Blood Glucose Monitoring Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holdings (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glysens Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARKRAY, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgaMatrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trividia Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MediWise Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaMonTech AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinocare, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menarini Diagnostics (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beurer GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prodigy Diabetes Care, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

血糖モニタリングデバイスの市場規模、シェア、成長分析、製品別、用途別、地域別 - 産業予測、2024年～2031年

Blood Glucose Monitoring Devices Market Size, Share, Growth Analysis, By Product (Blood Glucose Monitors, Glucose Monitoring Strips), By Application (Hospitals and Clinics, Diagnostic Centers), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

血糖モニタリングデバイス市場：製品別

血糖モニタリングデバイス市場：用途別

血糖モニタリングデバイス市場規模：地域別